Covid-19 drug to cost government entities US$2,340 for 5-day course
Tue, Jun 30, 2020 - 5:50 AM
Gilead's chief executive Mr O'Day says Gilead wants to price Remdesivir in a way that would give patients access to it.
GILEAD Sciences said it will charge the US government and other developed countries US$390 per vial for its coronavirus-fighting drug Remdesivir, or about US$2,340 for a typical five-day course of treatment.
The company said in a statement on Monday that it would offer...